Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3
NCT02843035Phase 2Active, not recruiting
- Sponsor
- Sanofi
- Start
- Jan 2017
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of venglustat in Gaucher disease type 3, sponsored by Sanofi. Started Jan 2017; status: active, not recruiting.
02
Drugs
venglustat
03
Conditions
Gaucher disease type 3
Beyond the preview
Go deeper on NCT02843035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02843035.